Trade press release

GEA separation technology for bioveterinary center in Angola

January 14, 2026

The new Veterinary Vaccine Institute in Huambo, Angola, is equipped with state-of-the-art separation technology. A CSC 6 stainless steel disc centrifuge and a CIP (“Clean in Place”) system are being installed. (Photo: GEA)

The new Veterinary Vaccine Institute in Huambo, Angola, is equipped with state-of-the-art separation technology. A CSC 6 stainless steel disc centrifuge and a CIP (“Clean in Place”) system are being installed. (Photo: GEA)

GEA developed the CSC 6 centrifuge for the pharmaceutical biotechnology industry in accordance with the currently applicable cGMP requirements (“Current Good Manufacturing Practice”). (Photo: GEA)

GEA developed the CSC 6 centrifuge for the pharmaceutical biotechnology industry in accordance with the currently applicable cGMP requirements (“Current Good Manufacturing Practice”). (Photo: GEA)

GEA VESTA® sterile valves are part of GEA's aseptic valve technology and feature a completely hermetic sealing system. (Photo: GEA)

GEA VESTA® sterile valves are part of GEA's aseptic valve technology and feature a completely hermetic sealing system. (Photo: GEA)

Dr. Michael Golek

CONTACT

GEA の概要

GEA は、世界レベルの食品製造プロセス技術を有するとともに、乳業、飲料、パーソナル・ホームケア、化学など食品以外の幅広い分野にも実績があり、2019年度の連結売上高は約49億ユーロとなりました。

Stay informed!

Are you a journalist? Then sign up to our press mailing list and select the topics you would like to be informed about

Media Relations

GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476 Düsseldorf
Germany
pr@gea.com